Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03996239 · ClinicalTrials.gov registry record · NA

Researching the Effect of Aerobic Exercise on Cancer

A NA study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

Active
Registry status
NA
Development phase
38
Enrollment target
10
Study locations

NCT03996239: Active NA study of Cancer, sponsored by Memorial Sloan Kettering Cancer Center.

NCT03996239 is a NA study of Cancer that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 38 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The trial reports 10 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03996239, a NA study of Cancer, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
38 participants
Enrollment target
10
Study locations

Study Summary

This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?

Conditions Studied

Cancer

Interventions

  • OTHER blood draw
  • BEHAVIORAL exercise (walking)
  • OTHER plasma samples

Study Locations (10)

New York

  • Memorial Sloan Kettering Commack - Commack
  • Memorial Sloan Kettering Westchester - Harrison
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan Kettering Nassau - Uniondale

New Jersey

  • Memorial Sloan Kettering Monmouth - Middletown
  • Memorial Sloan Kettering Bergen - Montvale

North Carolina

  • LABORATORY CORPORATION OF AMERICA HOLDINGS (Data or Specimen Analysis Only) - Burlington
  • Duke University Medical Center (Data or Specimen Analysis Only) - Durham

California

  • University of California, Los Angeles (Data or Specimen Analysis Only) - Los Angeles

Colorado

  • SOMALOGIC (Data or Specimen Analysis Only) - Boulder

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2019-06-20
Est. Completion 2026-06
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03996239

The ClinicalTrials.gov registry entry for NCT03996239 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (99% lower). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which blood draw is the first listed.

NCT03996239 reports 10 study locations spanning 5 distinct geographic areas - top geographies include New York, New Jersey, North Carolina.

Frequently Asked Questions

What is clinical trial NCT03996239 about?

NCT03996239 is a clinical study titled "Researching the Effect of Aerobic Exercise on Cancer". This study is being done to answer the following question: Will aerobic exercise (exercise that stimulates and strengthens the heart and lungs, and improves the body's use of oxygen) change the biomarkers (signs of disease) found in the blood?

What is the current status of trial NCT03996239?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 38 participants. The study started on 2019-06-20. Estimated completion is 2026-06.

What conditions does trial NCT03996239 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT03996239?

The interventions under investigation include: blood draw (OTHER), exercise (walking) (BEHAVIORAL), plasma samples (OTHER).

Who is sponsoring clinical trial NCT03996239?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03996239 being conducted?

This trial has 10 study locations across California, Colorado, New Jersey, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cancer

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.